איקסמפרה 15 מ"ג

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

IXABEPILONE 15 MG

Mevcut itibaren:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATC kodu:

L01DC04

Farmasötik formu:

POWDER FOR CONCENTRATE FOR INFUSION

Uygulama yolu:

I.V

Tarafından üretildi:

CORDEN PHARMA LATINA S.P.A., ITALY

Terapötik grubu:

IXABEPILONE

Terapötik endikasyonlar:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.

Yetkilendirme tarihi:

2012-01-01